MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

被引：1
|
作者：
Panes, Julian
Rubin, David T.
Vermeire, Severine
Lindsay, James O.
Sands, Bruce E.
Su, Chinyu
Friedman, Gary
Zhang, Haiying
Kayhan, Cem
Manuchehri, Alireza
Healey, Paul J.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)32148-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1932
引用
收藏
页码：S601 / S602
页数：3
相关论文
共 50 条
  • [1] MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Panes, J.
    Rubin, D. T.
    Vermeire, S.
    Lindsay, J. O.
    Sands, B. E.
    Su, C.
    Friedman, G.
    Zhang, H.
    Kayhan, C.
    Manuchehri, A.
    Healey, P.
    [J]. GUT, 2017, 66 : A121 - A122
  • [2] Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis
    Panes, J.
    Rubin, D. T.
    Vermeire, S.
    Lindsay, J. O.
    Sands, B. E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S315 - S317
  • [3] Improvement in patient-reported outcomes in 2 Phase 3 studies of tofacitinib in patients with moderately to severely active ulcerative colitis
    Panes, J.
    Su, C.
    Marren, A.
    Yu, D.
    Woodworth, D.
    Zhang, H.
    Healey, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S283 - S284
  • [4] A PHASE 3 STUDY OF VEDOLIZUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN JAPANESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Watanabe, Mamoru
    Motoya, Satoshi
    Watanabe, Kenji
    Ogata, Haruhiko
    Kanai, Takanori
    Matsui, Toshiyuki
    Suzuki, Yasuo
    Shikamura, Mitsuhiro
    Igeta, Masataka
    Oda, Kazunori
    Hori, Tetsuharu
    Araki, Takahiro
    Hibi, Toshifumi
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S380 - S381
  • [5] Improvement in Patient-Reported Outcomes in Two Phase 3 Induction Studies of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis
    Panes, Julian
    Su, Chinyu
    Marren, Amy
    Yu, Dahong
    Woodworth, Deborah A.
    Zhang, Haiying
    Healey, Paul J.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S1003 - S1003
  • [6] Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
    Panes, Julian
    Loftus, Edward, V
    Higgins, Peter D. R.
    Lindsay, James O.
    Zhou, Wen
    Yao, Xuan
    Ilo, Dapo
    Phillips, Charles
    Tran, Jacinda
    Sanchez Gonzalez, Yuri
    Vermeire, Severine
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, : 1421 - 1430
  • [7] Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND Study
    Louis, E.
    Panaccione, R.
    Parkes, G.
    Peyrin-Biroulet, L.
    Ferrante, M.
    Hisamatsu, T.
    Siegmund, B.
    Kalabic, J.
    Levine, P.
    Neimark, E.
    Wallace, K.
    Chen, S.
    Cheng, L.
    Duan, W. R.
    Armuzzi, A.
    Biederman, L.
    Loftus, E.
    Melmed, G.
    Schreiber, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I10 - I12
  • [8] Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance
    Nwaogu, Akudo
    Bond, Ashley
    Smith, Philip J.
    [J]. FRONTLINE GASTROENTEROLOGY, 2021, 12 (02) : 133 - 136
  • [9] AN ECONOMIC EVALUATION OF TOFACITINIB IN THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE UNITED KINGDOM
    Diamantopoulos, A.
    Lohan, C.
    LeReun, C.
    Wright, E.
    Bohm, N.
    Sawyer, L.
    [J]. VALUE IN HEALTH, 2019, 22 : S621 - S621
  • [10] Guselkumab Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the QUASAR Phase 3 Induction Study
    Bressler, Brian
    Feagan, Brian G.
    Panes, Julian
    Lichtenstein, Gary R.
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Pandya, Dwiti
    Han, Chenglong
    Miao, Ye
    Zhang, Hongyan
    Lateef, Syed
    Petroniene, Rima
    Rayyan, Yaser
    Peyrin-Biroulet, Laurent
    Rubin, David T.
    Hisamatsu, Tadakazu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S807 - S808
12345